Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


Premier Sponsors:  

Beckman Coulter Life Sciences 

Boston Healthcare

Cellecta  

Charles River Discovery

Elsevier 

 NanoString     

 SeraCare 

Silicon Biosystems   

 Streck 

 TriMetis


XIFIN

  View All Sponsors 


Cambridge Healthtech Institute’s 2nd Annual

Molecular Diagnostics for Infectious Disease

Advancing Molecular Diagnostics to Improve Detection and Patient Outcome

February 20-22, 2017 | Moscone North Convention Center | San Francisco, CA
Part of the 24th International Molecular Medicine Tri-Conference

 

With a growing number of technologies, tests, antibiotic-resistant bugs, and epidemics, molecular diagnostics are more important than ever for a wide range of infectious diseases. Molecular Diagnostics for Infectious Disease will return for its second year at the Molecular Medicine Tri-Conference to outline, discuss, and debate these challenges. This year, we will highlight advances in current and emerging technologies, including next-generation sequencing, and discuss the challenges in integrating these technologies in clinical labs. We will address the latest in rapid diagnostics for point-of-care testing, as well as challenges in diagnosing sepsis and epidemics like Zika and Ebola. This year, our discussion on antimicrobial resistance will focus on susceptibility testing, including emerging technologies for this use. We will again highlight novel approaches for infectious disease diagnostics, including using the microbiome, data, and host gene expression, as well as discuss continuing challenges like sample preparation and outcome studies. Join esteemed colleagues, service and technology providers, and peers to discuss these topics and more.

Who should attend: Clinical microbiologists, lab directors, researchers, and scientists from hospitals, laboratories, and academia working in fields such as clinical microbiology, infectious disease, molecular diagnostics, biomedical engineering, and laboratory medicine

Topics will include, but are not limited to:

  • NGS assays for diagnosis of infectious disease
  • Development of point-of-care assays
  • Rapid susceptibility testing of antimicrobials
  • Direct detection for sepsis
  • Diagnostics for epidemics such as Zika and Ebola
  • Pathogen detection by bioinformatics and whole-genome sequencing
  • Diagnostics using the human microbiome
  • Host gene expression for predicting infection
  • GI panel diagnostics
  • Outcome studies for validating assays for infectious disease diagnosis
  • Sample preparation challenges

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 29, 2016.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

For partnering and sponsorship information, please contact:

Kaitlin Searfoss
Conference Producer
Cambridge Healthtech Institute
Phone: (+1) 781-972-5498
Email: ksearfoss@healthtech.com

Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com

Joseph Vacca (Companies L-Z)
Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com